Literature DB >> 2211620

Overlapping Pit-1 and Sp1 binding sites are both essential to full rat growth hormone gene promoter activity despite mutually exclusive Pit-1 and Sp1 binding.

F Schaufele1, B L West, T L Reudelhuber.   

Abstract

A DNA-binding factor present in a wide variety of cell types is shown to bind to a site (GHF2) within the rat growth hormone gene promoter between nucleotides -147 and -129. Biochemical and transcriptional properties identify this factor as Sp1. The degree of glycosylation of one of the forms of Sp1 is observed to vary in a cell type-specific fashion. The GHF2 binding site overlaps with the more distal (dGHF1) of the two binding sites for the pituitary-specific transcription factor Pit-1. DNase I footprinting and gel retardation analysis with partially purified Sp1 and Pit-1 show that Sp1 and Pit-1 binding to these sites is mutually exclusive. Despite the inability of these two transcription factors to be simultaneously bound to their overlapping sites in vitro, the structural integrity of both binding sites appears essential to the maximal expression of the rat growth hormone promoter after transfection into pituitary GC cells. These findings suggest that activation of the rat growth hormone promoter by Sp1 and Pit-1 may occur through a multistage mechanism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2211620

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.

Authors:  D Mukhopadhyay; B Knebelmann; H T Cohen; S Ananth; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Interaction of basal positive and negative transcription elements controls repression of the proximal rat prolactin promoter in nonpituitary cells.

Authors:  S M Jackson; C A Keech; D J Williamson; A Gutierrez-Hartmann
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

3.  Pituitary development and physiology.

Authors:  Clement C Cheung; Robert H Lustig
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

4.  Overlapping DNA recognition motifs between Sp1 and a novel trans-acting factor within the wt1 tumour suppressor gene promoter.

Authors:  M T Discenza; M Dehbi; J Pelletier
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

5.  Molecular and functional characterization of the promoter region of the mouse LDH/C gene: enhancer-assisted, Sp1-mediated transcriptional activation.

Authors:  J Yang; K Thomas
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

6.  cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2.

Authors:  K Sogawa; H Imataka; Y Yamasaki; H Kusume; H Abe; Y Fujii-Kuriyama
Journal:  Nucleic Acids Res       Date:  1993-04-11       Impact factor: 16.971

7.  In vivo genomic footprinting of thyroid hormone-responsive genes in pituitary tumor cell lines.

Authors:  S W Kim; I M Ahn; P R Larsen
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

8.  Sp1 binds two sites in the CD11c promoter in vivo specifically in myeloid cells and cooperates with AP1 to activate transcription.

Authors:  J D Noti; B C Reinemann; M N Petrus
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  Participation of Ets transcription factors in the glucocorticoid response of the rat tyrosine aminotransferase gene.

Authors:  M L Espinás; J Roux; J Ghysdael; R Pictet; T Grange
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

Review 10.  Transcriptional regulation of multidrug resistance in breast cancer.

Authors:  R I Glazer; C Rohlff
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.